User profiles for L. Gillini

Rebecca L. Gillani

Instructor in Neurology, Massachusetts General Hospital, Harvard Medical School
Verified email at mgh.harvard.edu
Cited by 162

[HTML][HTML] Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009–15

…, E Cooreman, VRR Pemmaraju, L Gillini… - Clinical Microbiology …, 2018 - Elsevier
Objectives Antimicrobial resistance (AMR) is a priority for surveillance in bacterial infections.
For leprosy, AMR has not been assessed because Mycobacterium leprae does not grow in …

Changing clinical presentation and survival in HIV-associated tuberculosis after highly active antiretroviral therapy

…, A Ammassari, N Petrosillo, L Gillini… - JAIDS Journal of …, 2001 - journals.lww.com
Objective: To assess changes in clinical presentation and outcome of HIVassociated tuberculosis
(TB) before and after widespread implementation of highly active antiretroviral therapy (…

[HTML][HTML] An enhanced regimen as post-exposure chemoprophylaxis for leprosy: PEP++

…, J Grosset, HK Kar, S Izumi, L Gillini… - BMC infectious …, 2018 - Springer
The ongoing transmission of Mycobacterium (M.) leprae reflected in a very slow decline in
leprosy incidence, forces us to be innovative and conduct cutting-edge research. Single dose …

[HTML][HTML] Global practices in regard to implementation of preventive measures for leprosy

L Gillini, E Cooreman, T Wood… - PLoS neglected …, 2017 - journals.plos.org
The global incidence of leprosy is declining slowly, but it is not known why this is happening.
Suggested reasons include the gradually increasing global standard of living, increasing …

[HTML][HTML] Achieving a “step change” in the tuberculosis epidemic through comprehensive community-wide intervention: a model-based analysis

…, EA Kendall, R Chang, R Joseph, P Kasaie, L Gillini… - BMC medicine, 2021 - Springer
Background Global progress towards reducing tuberculosis (TB) incidence and mortality has
consistently lagged behind the World Health Organization targets leading to a perception …

Clinical and virological monitoring during treatment with intrathecal cytarabine in patients with AIDS-associated progressive multifocal leukoencephalopathy

…, A Cingolani, A Ammassari, L Gillini… - Clinical infectious …, 1999 - academic.oup.com
We describe the clinical and virological outcome of human immunodeficiency virus-infected
patients with progressive multifocal leukoencephalopathy (PML) treated with cytarabine. …

Key role of tuberculosis services funding mechanisms in tuberculosis control and elimination

…, A Hayrapetyan, M Dara, L Gillini… - European …, 2015 - Eur Respiratory Soc
… Karapet Davtyan, Armen Hayrapetyan, Masoud Dara, Laura Gillini, Hayk Davtyan, Rosella
Centis, Lia D’Ambrosio, Giovanni Sotgiu, Giovanni Battista Migliori … D’Ambrosio L, … Gillini L, …

[PDF][PDF] TB financing in East Europe promotes unnecessary hospital admissions: the case of Armenia

L Gillini, K Davtyan, H Davtyan, A Hayrapetyan… - The Journal of Infection …, 2013 - jidc.org
Background Based on cost-effectiveness considerations and on the risk of nosocomial
transmission of Mycobacterium tuberculosis strains, the World Health Organization (WHO) and …

[PDF][PDF] Implementing the Global Leprosy Strategy 2016–2020 in Nepal: Lessons learnt from active case detection campaigns

L Gillini, E Cooreman, B Pandey, C Bhandari… - Leprosy …, 2018 - leprosyreview.org
Background After reaching the goal of elimination of leprosy as a public health problem (point
prevalence, 1 per 10,000 population) at global level in 2000, new leprosy cases continue …

[PDF][PDF] Mediterranean Region

L Gillini, A Seita - AAAAAA SAAAAA AAAA AAAAA AAAAAA AAAAA, 2002 - apps.who.int
… Le VlH est le facteur de risque le plus important pour le passage de l'infection à … sur l'épidémiologie
de la tuberculose dans la Région, il est nécessaire de lutter conjointement contre l'…